Fig. 2. Expression of KRASG12D in granulosa cells causes multiple
reproductive defects. (A) Continuous breeding assay showing the
cumulative number of progeny per female. The
LSL-KrasG12D;Amhr2-Cre and
LSL-KrasG12D;Cyp19-Cre females (n=6) were
subfertile. (B) Superovulation experiments showing that the ovulation
rate in response to gonadotropins was reduced in Kras mutant mice
(n=10) as compared with the wild type (WT). (C-J) Histology of
WT (C,E,G,I) and LSL-KrasG12D;Amhr2-Cre (D,F,H,J) ovaries
at 8 (C-F), 16 (G,H) and 48 (I,J) hours after hCG treatment. Histology of WT
(I) and LSL-KrasG12D;Amhr2-Cre (J) ovaries 48 hours after
hCG treatment shows that an oocyte is trapped in the corpus luteum of the
Kras mutant ovary (arrow).